Supernus Pharmaceuticals, Inc. (SUPN)
MD
Total Compensation for Fiscal Year Ending in 2023: $13,278,093
| Salary | $963,000 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $4,760,000 |
| Value of Option Awards | $6,675,200 |
| Non-Equity Incentive Plan Compensation | $830,588 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $49,305 |
| Total | $13,278,093 |
Supernus Pharmaceuticals, Inc. disclosed its CEO pay was
80
times its median employee's pay for the fiscal year ending in 2023.
How Do You Compare?
